The Claim

Daily administration of 10 mg rosuvastatin for 24 weeks reduces lipoprotein-associated phospholipase A2 (Lp-PLA2) levels by approximately 10% in HIV-infected adults on stable antiretroviral therapy with suppressed viral load and normal LDL cholesterol, independent of changes in LDL cholesterol, indicating a direct anti-inflammatory effect on vascular tissue.

Source: Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
72score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Taking 10 mg of rosuvastatin daily for 24 weeks lowers Lp-PLA2 levels by about 10% in HIV-positive adults with controlled virus and normal LDL cholesterol, even when LDL cholesterol does not change, showing a direct reduction in vascular inflammation.

See the scientific wording

Twenty-four weeks of daily 10 mg rosuvastatin significantly reduces lipoprotein-associated phospholipase A2 (Lp-PLA2) levels by approximately 10% in HIV-infected adults on stable antiretroviral therapy with suppressed viral load and normal LDL cholesterol, independent of LDL reduction, suggesting a direct anti-inflammatory effect on vascular tissue.

Why this might work

Rosuvastatin blocks a key step in cholesterol production inside immune cells called macrophages, which stops a signaling molecule from activating a protein that turns on inflammation genes. This turns down the production of an enzyme that breaks down fats in artery walls, reducing the creation of inflammatory chemicals that damage blood vessels.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.

    Taking 10 mg of rosuvastatin daily for 6 months lowered a blood marker of artery inflammation by 10% in people with HIV who were already well-controlled on their meds — even though their cholesterol didn’t go up, meaning the drug likely calms blood vessel inflammation directly.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.